查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566956

乙醇脫氫酶市場：按類型、按應用分類：2024-2033 年全球機會分析與產業預測

Alcohol Dehydrogenase Market By Type (Medium-chain Enzymes, Short-chain Enzymes) , By Application (Alcohol Concentration Detection, Disease Diagnosis, Catalyst) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年乙醇脫氫酶市值為6億美元，預計2024年至2033年複合年成長率為6.5%，到2033年將達11億美元。

乙醇脫氫酶是一種含鋅酶，主要負責將酒精氧化成醛和酮。這種酵素主要在人類肝臟和胃中合成，是對抗有毒分子酒精的主要防禦手段。酒精脫氫酶在使這種潛在有害分子對食品無害方面發揮重要作用，從而防止毒性水平的積累並排放體內的酒精。

全球酒精脫氫酶市場的成長主要是由全球酒精消費量的增加以及酒精相關疾病盛行率的驚人增加所推動的。這是因為乙醇脫氫酶可以減輕酒精的中毒作用並促進其從體內排出。根據世界衛生組織（WHO）的說法，酒精是一種已知的致癌物質，並且會增加癌症的風險。 2019 年，約有 401,000 人因飲酒而死亡。此外，人們對酒精相關健康問題的認知不斷提高，以及對有效診斷工具和治療的需求正在推動對乙醇脫氫酶的需求。此外，綠色化學中擴大採用醇脫氫酶對市場成長做出了重大貢獻。然而，乙醇脫氫酶的高製造成本限制了市場的成長。此外，製造過程的複雜性、對先進技術和熟練技術人員的需求導致了額外的成本，這進一步限制了市場的成長。相反，診斷技術的進步，例如更準確、更有效地測量乙醇脫氫酶活性的檢測方法，預計將為預測期內的市場成長提供有利的機會。此外，生物技術和酵素工程的創新正在促進新的乙醇脫氫酶產品和應用的開拓，例如重組乙醇脫氫酶和改進的診斷分析，預計將為市場擴張開闢新的途徑。

乙醇脫氫酶產業按類型、應用和區域細分。依類型，市場分為中鏈酶和短鏈酶。依用途分為酒精濃度檢測、疾病診斷、催化劑等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，中鏈細分市場將在 2023 年佔據市場主導地位。

從應用來看，2023年酒精濃度檢測領域將佔據主要市場佔有率。

按地區分類，北美地區 2023 年成長最快。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 歷史市場資料
  • 贖回場景

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章醇脫氫酶市場：依類型

  • 市場概況
  • 中鏈酶
  • 短鏈酶

第5章醇脫氫酶市場：依應用分類

  • 市場概況
  • 酒精濃度檢測
  • 疾病診斷
  • 催化劑

第6章酒精分解酵素市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國乙醇脫氫酶市場
    • 加拿大乙醇脫氫酶市場
    • 墨西哥乙醇脫氫酶市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國乙醇脫氫酶市場
    • 德國乙醇脫氫酶市場
    • 義大利乙醇脫氫酶市場
    • 西班牙乙醇脫氫酶市場
    • 英國乙醇脫氫酶市場
    • 其他歐洲醇脫氫酶市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國乙醇脫氫酶市場
    • 日本乙醇脫氫酶市場
    • 印度乙醇脫氫酶市場
    • 韓國乙醇脫氫酶市場
    • 澳洲乙醇脫氫酶市場
    • 其他亞太醇脫氫酶市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西乙醇脫氫酶市場
    • 南非乙醇脫氫酶市場
    • 沙烏地阿拉伯乙醇脫氫酶市場
    • 其他拉丁美洲/中東/非洲乙醇脫氫酶市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Creative Enzymes Technologies, LLC
  • MP Biomedicals
  • Randox Laboratories Limited
  • Sekisui Diagnostics
  • Prospec-Tany Technogene Ltd.
  • Roche Diagnostics
  • Worthington Biochemical Corp.
簡介目錄
Product Code: A324360

The alcohol dehydrogenase market was valued at $0.6 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.

Alcohol dehydrogenase is class of zinc-containing enzyme that is majorly responsible for the oxidation of alcohols to aldehydes or ketones. This enzyme is predominantly synthesized liver and stomach of humans that acts as a primary defense against a toxic molecule, alcohol. Alcohol dehydrogenase detoxifies this potentially harmful molecule into a mere foodstuff, thereby playing a critical role in preventing the accumulation of toxic levels and eliminating alcohol from the body.

The growth of the global alcohol dehydrogenase market is majorly driven by rise in global alcohol consumption and alarming increase in prevalence of alcohol-related diseases. This is attributed to the fact that alcohol dehydrogenase mitigates the intoxicating effects of alcohol and facilitates its excretion from the body. According to the World Health Organization, alcohol is an established carcinogen and is known to increase the risk of cancer. Approximately 401,000 cancer deaths were registered in 2019 due to alcohol consumption. In addition, rise in awareness about alcohol-related health issues and the need for effective diagnostic tools and treatments boosts the demand for alcohol dehydrogenase. Moreover, increase in adoption of alcohol dehydrogenase in green chemistry notably contributes toward the growth of the market. However, high production cost of alcohol dehydrogenase restrains the growth of the market. Furthermore, the complexity associated with the production process and the need for advanced technology and skilled technicians incur additional costs, which further restrict the market growth. On the contrary, advances in diagnostic technologies, such as more accurate and efficient assays for measuring alcohol dehydrogenase activity, are expected to offer remunerative opportunities for the market growth during the forecast period. Furthermore, technological innovations in biotechnology and enzyme engineering contribute to the development of new alcohol dehydrogenase products and applications, including recombinant alcohol dehydrogenase enzymes and improved diagnostic assays, which are anticipated to open new avenues for the expansion of the market.

The alcohol dehydrogenase industry is segmented into type, application, and region. On the basis of type, the market is bifurcated into medium-chain enzymes and short-chain enzymes. On the basis of application, the market is segregated into alcohol concentration detection, disease diagnosis, and catalyst. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the medium-chain segment dominated the market in 2023.

On the basis of application, the alcohol concentration detection segment held a major share of the market in 2023.

Region wise, North America exhibited the highest growth in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global alcohol dehydrogenase market include Sigma-Aldrich, Thermo Fisher Scientific, BioVision Inc., Creative Enzymes Technologies, LLC, MP Biomedicals, Randox Laboratories Limited, Sekisui Diagnostics, Prospec-Tany Technogene Ltd., Roche Diagnostics, and Worthington Biochemical Corporation These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Type

  • Medium-chain Enzymes
  • Short-chain Enzymes

By Application

  • Alcohol Concentration Detection
  • Disease Diagnosis
  • Catalyst

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Sigma-Aldrich
    • Thermo Fisher Scientific Inc.
    • BioVision Inc.
    • Creative Enzymes Technologies, LLC
    • MP Biomedicals
    • Randox Laboratories Limited
    • Sekisui Diagnostics
    • Prospec-Tany Technogene Ltd.
    • Roche Diagnostics
    • Worthington Biochemical Corp.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ALCOHOL DEHYDROGENASE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Medium-chain Enzymes
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Short-chain Enzymes
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Alcohol Concentration Detection
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Disease Diagnosis
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Catalyst
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ALCOHOL DEHYDROGENASE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Alcohol Dehydrogenase Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Alcohol Dehydrogenase Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Alcohol Dehydrogenase Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Alcohol Dehydrogenase Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. Germany Alcohol Dehydrogenase Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. Italy Alcohol Dehydrogenase Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Spain Alcohol Dehydrogenase Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. UK Alcohol Dehydrogenase Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Alcohol Dehydrogenase Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Alcohol Dehydrogenase Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. Japan Alcohol Dehydrogenase Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. India Alcohol Dehydrogenase Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. South Korea Alcohol Dehydrogenase Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. Australia Alcohol Dehydrogenase Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Alcohol Dehydrogenase Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Alcohol Dehydrogenase Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. South Africa Alcohol Dehydrogenase Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. Saudi Arabia Alcohol Dehydrogenase Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Alcohol Dehydrogenase Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Sigma-Aldrich
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Thermo Fisher Scientific
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. BioVision Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Creative Enzymes Technologies, LLC
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. MP Biomedicals
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Randox Laboratories Limited
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Sekisui Diagnostics
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Prospec-Tany Technogene Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Roche Diagnostics
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Worthington Biochemical Corp.
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments